• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.17% Nasdaq Down1.19%

    More On SNY


    Sanofi (SNY)

    -NYSE
    42.85 Down 0.77(1.77%) Apr 28, 4:01PM EDT
    ProfileGet Profile for:
    Sanofi
    54, Rue La Boétie
    Paris, 75008
    France - Map
    Phone: 33 1 53 77 40 00
    Fax: 33 1 53 77 42 96
    Website: http://www.sanofi.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Sanofi researches, develops, manufactures, and markets various therapeutic solutions. The company operates in three segments: Pharmaceuticals, Vaccines, and Animal Health. It offers Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; Toujeo, an insulin glargine; and Afrezza, an inhaled insulin. The company also provides Praluent, a human monoclonal antibody; and Multaq, a multichannel blocker with anti-arrhythmic properties. In addition, it offers Cerezyme, an enzyme replacement therapy to treat gaucher disease; cerdelga, an oral therapy for Gaucher disease Type 1; Myozyme/Lumizyme for the pompe disease treatment; Fabrazyme for fabry disease treatment; and Aldurazyme to treat mucopolysaccharidosis Type 1, as well as provides Aubagio and Lemtrada for multiple sclerosis. In addition, it provides Jevtana for prostate cancer; Taxotere for breast, prostate, gastric, lungs, and head and neck cancer treatment; Eloxatin for the treatment of stage III colon cancer; Thymoglobulin to treat acute rejection; Mozobil for treating hematologic malignancies; and Zaltrap for oxaliplatin resistant metastatic colorectal cancer. Further, the company offers other prescription drugs, such as Plavix/Iscover for atherothrombosis and acute coronary syndrome; Lovenox/Clexane for the treatment of venous thromboembolism; Aprovel/Avapro/Karvea for hypertension and nephropathy; Renagel/Renvela to treat chronic kidney disease; Allegra/Telfast to treat seasonal allergic rhinitis and uncomplicated hives; Stilnox/Ambien/Myslee for insomnia treatment; and Synvisc/Synvisc-One for the treatment of osteoarthritis pain. Additionally, it offers consumer health care products and generic medicines; and vaccine and animal health products. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sanofi

    Key Executives 
     PayExercised
    Mr. Olivier Brandicourt , 60
    Chief Exec. Officer, Director and Member of Strategy Committee
    4.95MN/A
    Mr. Jérôme Contamine , 58
    Chief Financial Officer and Exec. VP
    N/AN/A
    Mr. Laurent Gilhodes ,
    Principal Accounting Officer and VP of Corp. Accounting
    N/AN/A
    Mr. Bruno Ménard ,
    Chief Information officer
    N/AN/A
    Mr. Sébastien Martel ,
    VP of Investor Relations
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.